Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
287
-
Total 13F shares, excl. options
-
52,085,929
-
Shares change
-
-1,274,763
-
Total reported value, excl. options
-
$5,676,848,580
-
Value change
-
-$158,899,374
-
Put/Call ratio
-
169%
-
Number of buys
-
128
-
Number of sells
-
185
-
Price
-
$109.03
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2016
As of 31 Dec 2016 Jazz Pharmaceuticals plc - SHS USD (JAZZ) had 287 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 52,085,929 shares of stock of the company.
Largest 10 holders included PUTNAM INVESTMENTS LLC, FMR LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, CADIAN CAPITAL MANAGEMENT, LP, Bank of New York Mellon Corp, WESTFIELD CAPITAL MANAGEMENT CO LP, FIL Ltd, BlackRock Fund Advisors, and BlackRock Institutional Trust Company, N.A..
This table shows 288 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.